Rani Therapeutics Holdings, Inc. (RANI) SEC Filings — 2025
15 SEC filings for Rani Therapeutics Holdings, Inc. (RANI) in 2025.
Filings
- Rani Therapeutics Narrows Q3 Loss, Boosts Cash Amid Asset Shift — 10-Q · Nov 6, 2025
- Rani Therapeutics Appoints New Director, Board Changes — 8-K · Oct 27, 2025
- Rani Therapeutics Files 8-K on Key Agreements and Sales — 8-K · Oct 17, 2025
- Rani Therapeutics Narrows Q2 Loss Amidst Continued R&D Spend — 10-Q · Aug 7, 2025
- Rani Therapeutics Files 8-K: Other Events & Exhibits — 8-K · Jul 16, 2025
- Rani Therapeutics Faces Delisting Concerns — 8-K · Jun 26, 2025
- Rani Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · May 29, 2025
- Rani Therapeutics Files 8-K: Agreements & Equity Sales — 8-K · May 20, 2025
- Rani Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Rani Therapeutics Faces Delisting Notice — 8-K · May 6, 2025
- Rani Therapeutics Files Proxy Supplement for May 28 Meeting — DEFA14A · Apr 30, 2025
- Rani Therapeutics Files 8-K on Officer/Director Changes — 8-K · Apr 30, 2025
- Rani Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 16, 2025
- Rani Therapeutics Appoints PricewaterhouseCoopers as New Auditor — 8-K · Apr 9, 2025
- Rani Therapeutics Holdings, Inc. 10-K Filing — 10-K · Mar 31, 2025